Introduction

Nanocarrier-based Drug Delivery for the Management of Fatty Liver Disease is an advanced exploration of nanotechnology-driven therapeutic strategies for the diagnosis and treatment of fatty liver disease that is positioned at the intersection of nanomedicine, pharmacology, hepatology, and drug delivery.

The book begins with foundational concepts of fatty liver disease and its metabolic implications before introducing various nanocarrier-based drug delivery systems and liver-targeting strategies. Dedicated chapters discuss lipid-based nanocarriers, polymeric nanoparticles, dendrimers, and hybrid nanocarrier systems for therapeutic applications. It further explores novel therapeutics, nanocarrier-based imaging agents for diagnosis, pharmacokinetics and pharmacodynamics, and the safety and toxicity aspects of nanomedicine. Clinical translation, real-world case studies, and emerging trends in nanocarrier-assisted liver disease management are also comprehensively examined.

Key Features

• - Comprehensive coverage of nanocarrier systems for fatty liver disease treatment.
• - Discussions of lipid-based, polymeric, dendrimer, and hybrid nanocarriers.
• - Insights into liver-targeted drug delivery and imaging technologies.
• - Coverage of pharmacokinetics, toxicity, and clinical translation challenges.
• - Focuses on emerging therapeutic strategies and future developments in nanomedicine.

Target Readership :

Researchers, clinicians, pharmacologists, scientists, postgraduate students, and academics in hepatology, pharmaceutical sciences, nanomedicine, drug delivery, and biomedical research.